| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |